Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

4 results about "Methylsulfonylmethane" patented technology

Methylsulfonylmethane (MSM) has been used for pain and swelling of the joints caused by osteoarthritis.

Application of methylsulfonylmethane in preparation of product for treating asthenospermia

The invention provides an application of methylsulfonylmethane in preparation of a product for treating asthenospermia. The research of the invention finds that the sulfhydrylation modification level of ATP synthetase can be effectively changed by using methylsulfonylmethane as an active component, so that the intracellular energy metabolism state of sperms is regulated and controlled, and the motility of the sperms is further changed.
Owner:SHANGHAI INST FOR BIOMEDICAL & PHARM TECH

External transdermal enhanced gel composition for nursing joints of dogs and cats and preparation method of external transdermal enhanced gel composition

PendingCN122031545AHydroxy compound active ingredientsAerosol deliveryMethylsulfonylmethaneLiposome
The invention relates to an external transdermal enhanced gel composition for nursing joints of dogs and cats and a preparation method of the external transdermal enhanced gel composition, and belongs to the technical field of pet health care and health care. The gel composition comprises: a) 1.0-2.5% of a gel matrix, wherein the gel matrix comprises xanthan gum and gellan gum in a weight ratio of (3-1): 1; b) 6-20% of an active care component, wherein the active care component comprises a frankincense extract, glucosamine hydrochloride, low molecular weight chondroitin sulfate, menthol and methylsulfonylmethane; c) 7-20% of a transdermal enhancing component, the transdermal enhancing component comprises azone, propylene glycol and curcumin-loaded anion liposome dispersion liquid, the weight ratio of azone to propylene glycol is 1: (1.5-3), and the solid weight of the anion liposome accounts for 0.5-2.0% of the total weight of the gel composition. The composition has excellent transdermal performance, exact anti-inflammatory and analgesic effects and excellent pet nursing compliance.
Owner:JIANGSU CHOMPING PET PROD CO LTD

Pharmaceutical composition

PendingJP2026519984AAerosol deliveryInorganic non-active ingredientsDiseaseMethylsulfonylmethane
Pharmaceutical compositions of alpha-lipoic acid and / or methylsulfonylmethane (MSM) and magnesium salts, useful for the treatment, prevention, or reduction of the severity of viral infections and / or skin diseases, are provided herein. Methods for preparing the pharmaceutical compositions and methods for using the pharmaceutical compositions in therapeutic treatments are also provided.
Owner:エアロテック オーストラリア ピーティーワイ エルティーディー

Aqueous sodium-ion battery electrolyte as well as preparation method and application thereof

The invention provides an aqueous sodium-ion battery electrolyte as well as a preparation method and application thereof, and belongs to the technical field of electrochemical energy storage. The aqueous sodium-ion battery electrolyte provided by the invention comprises the following components: sodium salt, water, an organic cosolvent, an ether diluent, ethylene glycol dimethyl ether and methylsulfonylmethane, the concentration of the sodium salt is 1-8 mol / kg; the volume ratio of the water to the organic cosolvent is 1: (3-7); the volume ratio of the ether diluent to the organic cosolvent is (0.1-0.5): 1. The voltage window is widened by limiting the volume ratio of water to the organic cosolvent and the volume ratio of the ether diluent to the organic cosolvent; ethylene glycol dimethyl ether forms an SEI film which is more stable and lower in impedance, and the ethylene glycol dimethyl ether and the ether diluent have a synergistic effect, so that a local low-water-activity environment is created; methylsulfonylmethane is preferentially decomposed on the surface of the negative electrode, so that the electrochemical performance is improved.
Owner:SHANGHAI SECOND POLYTECHNIC UNIVERSITY